Contributions
Abstract: EP1551
Type: ePoster
Abstract Category: Therapy - disease modifying - Others
Background: Relapsing -remitting MS (RR-MS) is the most common type of MS. It is characterized by relapses, which means new neurological symptoms or worsening of the old ones, lasting at least 24 hours in the absence of any infection or fever. Standard care for flares up is intravenous high dose of corticosteroids (HDC).
Goals: The present study aimed to explore how well our RRMS patients understand the meaning of a relapse and what is their reaction when experience new symptoms. Furthermore, we tried to find out if they were well informed about the necessity and side effects of HDC.
Methods: 68 subjects (n= 44 women) , 18 to 67 years old (mean= 47 years) completed a 20-item self-administrated anonymous questionnaire in order to collect information on demographics, disease evolution, perception of a relapse and benefits and side effects of HDC.
Results: The majority of the patients (76%) admitted they were informed about relapse"s definition. Although 90% of all patients gave correct definition of a relapse, they were wrong about the duration of symptoms and only 19% of our cohort gave a right answer. Furthermore, 81% of all patients believe that HDC course is necessary for resolution of their symptoms. Regarding the side effects of HDC, 46 % of all patients consider them present only during the administration period.
Conclusion: Physicians should explain patients more comprehensively about the nature of a relapse, which of them should treat, as well as the benefits and drawbacks of HDC treatment.
Disclosure: Charisiou Kleoniki Maria: Nothing to disclose
Katsavarou Ourania: Nothing to disclose
Kyritsis Athanasios: Nothing to disclose
Pelidou Sygkliti Henrietta; Nothing to disclose
Abstract: EP1551
Type: ePoster
Abstract Category: Therapy - disease modifying - Others
Background: Relapsing -remitting MS (RR-MS) is the most common type of MS. It is characterized by relapses, which means new neurological symptoms or worsening of the old ones, lasting at least 24 hours in the absence of any infection or fever. Standard care for flares up is intravenous high dose of corticosteroids (HDC).
Goals: The present study aimed to explore how well our RRMS patients understand the meaning of a relapse and what is their reaction when experience new symptoms. Furthermore, we tried to find out if they were well informed about the necessity and side effects of HDC.
Methods: 68 subjects (n= 44 women) , 18 to 67 years old (mean= 47 years) completed a 20-item self-administrated anonymous questionnaire in order to collect information on demographics, disease evolution, perception of a relapse and benefits and side effects of HDC.
Results: The majority of the patients (76%) admitted they were informed about relapse"s definition. Although 90% of all patients gave correct definition of a relapse, they were wrong about the duration of symptoms and only 19% of our cohort gave a right answer. Furthermore, 81% of all patients believe that HDC course is necessary for resolution of their symptoms. Regarding the side effects of HDC, 46 % of all patients consider them present only during the administration period.
Conclusion: Physicians should explain patients more comprehensively about the nature of a relapse, which of them should treat, as well as the benefits and drawbacks of HDC treatment.
Disclosure: Charisiou Kleoniki Maria: Nothing to disclose
Katsavarou Ourania: Nothing to disclose
Kyritsis Athanasios: Nothing to disclose
Pelidou Sygkliti Henrietta; Nothing to disclose